Benactyzine

Benactyzine
Systematic (IUPAC) name
2-(diethylamino)ethyl hydroxy(diphenyl)acetate
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration		 Oral
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 302-40-9 YesY
ATC code none
PubChem CID 9330
DrugBank DB09023 N
ChemSpider 8966 YesY
UNII 595EG71R3F YesY
KEGG D07498 YesY
ChEMBL CHEMBL70352 YesY
Chemical data
Formula C20H25NO3
Molar mass 327.417 g/mol
 NYesY (what is this?)  (verify)

Benactyzine is an anticholinergic drug that was used as an antidepressant in the treatment of depression and associated anxiety before it was pulled from the U.S. market by the FDA due to its ineffectiveness.[1]

Its use for these indications was limited by side effects such as dry mouth and nausea, and at high doses it can cause more severe symptoms such as deliriant and hallucinogenic effects.[1]

Brand names have included: Suavitil, Phebex, Phobex, Cedad, Cevanol, Deprol, Lucidil, Morcain, Nutinal, Parasan. While there was some tentative evidence when combined with meprobamate with the medication no longer available it is not clinical important.[2]

History

Benactyzine was brought to market in the US in 1957 by Merck under the tradename, Suavitil.[3]

See also

3-Quinuclidinyl benzilate

References

  1. 1 2 Shorter, E., Looking backwards: a possible new path for drug discovery in psychopharmacology. Nat Rev Drug Discov 2002, 1 (12), 1003-1006.
  2. ↑ DeBattista, Alan F. Schatzberg, Jonathan O. Cole, Charles (2010). Manual of clinical psychopharmacology (7th ed.). Washington, DC: American Psychiatric Pub. p. 423. ISBN 9781585623778.
  3. ↑ Smith, Mickey C., PhD. Principles of Pharmaceutical Marketing, Third Edition. 3rd ed. New York: Routledge, 2013. Print. ISBN 9781317940715


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.